Mapping of Electrical Properties in the Brain
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06470711
- Status
- Recruiting
Conditions
- Malignant Glioma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Non-Interventional Study — OTHERNon-interventional study
Study Details
This study evaluates imaging methods for monitoring neural and electrical activity in the brain for improving clinical diagnosis.
Key Dates
- Start date
- Sep 13, 2024
- Status verified
- Jan 2026
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 120 participants (estimated)
Arms
- Arm: ObservationalParticipants complete a survey and undergo MRI on study.
Primary Outcome Measure
Identify diffusion MRI metrics [using conductivity tensor imaging (CTI)] that inform of regional electrical properties in the brain [ Time Frame: Baseline ]
Central Contacts
- Clinical Trials Referral Office855-776-0015
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Arizona | Scottsdale | Arizona | 85259 | Leland S. Hu, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Scottsdale, AZ
By research site
Related Studies
- Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma TrialPHASE1 · Recruiting · Mayo Clinic · Phoenix, Arizona
- A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)PHASE1/PHASE2 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing SurgeryPHASE1/PHASE2 · Recruiting · Stanford University · Palo Alto, California
- Non-invasive Glioma Characterization Through Molecular ImagingRecruiting · University of Miami · Miami, Florida